These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [STDs would be better cured than prevented?]. Nau JY Rev Med Suisse; 2010 Sep; 6(261):1686-7. PubMed ID: 20939406 [No Abstract] [Full Text] [Related]
43. Current concepts in the treatment of gonorrhea and syphilis. Kampmeier RH South Med J; 1975 Oct; 68(10):1198-9. PubMed ID: 1166326 [No Abstract] [Full Text] [Related]
44. VD--everyone's concern. Brown WJ J Am Pharm Assoc; 1971 Aug; 11(8):422-3. PubMed ID: 5171208 [No Abstract] [Full Text] [Related]
45. [The optimal time periods for the treatment of patients with venereal diseases at the hospital and at the outpatient clinic]. Voronenko IuV; Martynenko AV Lik Sprava; 1993 Jan; (1):111-4. PubMed ID: 8379127 [TBL] [Abstract][Full Text] [Related]
47. [Is the infectious diseases law a barricade in the VD campaign? II]. Lidén S; Danielsson D; Falk V; Wallin J Lakartidningen; 1973 Jan; 70(5):362-5. PubMed ID: 4739275 [No Abstract] [Full Text] [Related]
48. A national strategic plan for reducing the burden of sexually transmitted infections in Israel by the year 2025. Chemtob D; Gandacu D; Mor Z; Grotto I; Anis E; Rosenberg E Isr J Health Policy Res; 2017; 6():23. PubMed ID: 28428838 [TBL] [Abstract][Full Text] [Related]
49. Public health nursing in the control of syphilis and gonorrhea. STIVER P Can J Public Health; 1946 Jun; 37():249. PubMed ID: 20990560 [No Abstract] [Full Text] [Related]
50. Sexually transmitted diseases of the vulva. Elgart ML Dermatol Clin; 1992 Apr; 10(2):387-403. PubMed ID: 1606766 [TBL] [Abstract][Full Text] [Related]
51. Screening for sexually transmitted diseases. U.S. Preventive Services Services Task Force, Washington, D.C. Am Fam Physician; 1990 Sep; 42(3):691-702. PubMed ID: 2203237 [No Abstract] [Full Text] [Related]
52. Modern venereal disease legislation in Denmark. Perdrup A Br J Vener Dis; 1973 Apr; 49(2):174-6. PubMed ID: 4740019 [No Abstract] [Full Text] [Related]
53. Public health nursing in the control of syphilis and gonorrhoea; public health objectives in venereal disease control. STIVER P Can J Public Health; 1946 Apr; 37():143-5. PubMed ID: 21027304 [No Abstract] [Full Text] [Related]
54. Vaccines for classic sexually transmitted diseases. Adimora AA; Sparling PF; Cohen MS Infect Dis Clin North Am; 1994 Dec; 8(4):859-76. PubMed ID: 7890936 [TBL] [Abstract][Full Text] [Related]
55. [Epidemiology of sex transmitted diseases and their control strategies in China]. Zhang J Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Aug; 21(4):304-5. PubMed ID: 15455474 [No Abstract] [Full Text] [Related]
57. The terrible peril: a historical perspective on the venereal diseases. Adler MW Br Med J; 1980 Jul; 281(6234):206-11. PubMed ID: 6996787 [No Abstract] [Full Text] [Related]
58. The Impact of a Social Marketing Campaign on HIV and Sexually Transmissible Infection Testing Among Men Who Have Sex With Men in Australia. Wilkinson AL; Pedrana AE; El-Hayek C; Vella AM; Asselin J; Batrouney C; Fairley CK; Read TR; Hellard M; Stoové M Sex Transm Dis; 2016 Jan; 43(1):49-56. PubMed ID: 26650997 [TBL] [Abstract][Full Text] [Related]
59. Sulfathiazole prophylaxis for gonorrhea and chancroid among soldiers in the Caribbean area. BERGSMA D Am J Syph Gonorrhea Vener Dis; 1946 Jul; 30():368-80. PubMed ID: 20992353 [No Abstract] [Full Text] [Related]
60. [Socio-epidemiologic characteristics of patients with syphilis and gonorrhea in recurrent venereal diseases]. Chuchelin GN; Vinokurov IN; Skuratovich AA Vestn Dermatol Venerol; 1983 Oct; (10):27-30. PubMed ID: 6689242 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]